UnitedHealth Group Inc

UnitedHealth Group Inc(UNH)股票分析

$395.620

+18.713 (+4.73%)收盤時

Loading chart…
最高
396.440
開盤
382.290
成交量加權均價
391.45
成交量
7.77M
市值
447.71B
最低
382.290
成交金額
3.04B
企業價值/稅息折舊攤銷前利潤(TTM)
10.46

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.

AI 分析 of UnitedHealth Group Inc (UNH)

買進

UnitedHealth Group is a good buy right now due to its solid fundamentals and positive market sentiment. The current price is $379.30, with a forward P/E ratio of 16.58, suggesting it is reasonably valued for future earnings growth. Additionally, analysts project earnings growth of over 13% annually in the next three to five years, which supports a bullish outlook. However, insider selling has surged by 2854.33% recently, indicating potential concerns about management confidence.

分析師評級(22)

上檔空間 +0.56%
買進
22 買進
0 持有
0 賣出
目前: 395.62
最低
330.00
平均
397.82
最高
444.00

TD Cowen

2026-10-09

目標價

$402

買進

Piper Sandler

2026-10-09

目標價

$14

增持

Erste Group

2026-08-27

目標價

—

持有

Mizuho

2026-07-21

目標價

$493

優於大盤

Wells Fargo

2026-07-20

目標價

$526

增持

估值指標

UnitedHealth Group Inc(UNH)目前預期本益比為 16.58,5 年平均預期本益比為 20.64。

預期本益比

低估
5 年均值 P/E
20.64
目前P/E
16.58
高估
23.92
低估
17.35

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
14.56
目前EV/EBITDA
10.46
高估
19.96
低估
9.16

預期股價營收比

低估
5 年均值 P/S
1.09
目前P/S
0.74
高估
1.39
低估
0.80

Alphio AI 對 UNH 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%UNH

$396.89

情境價格

基

基準

基準 · 50%UNH

$339.20

情境價格

悲

悲觀

悲觀 · 25%UNH

$315.88

情境價格

持有 UNH 的大戶

C

Corient Private Wealth LP

+ 持有UNH

+51.17%

3個月報酬率

T

Turtle Creek Management, LLC

+ 持有UNH

+21.39%

3個月報酬率

M

MUFG Securities EMEA plc

+ 持有UNH

+13.36%

3個月報酬率

W

W1M Investment Management Limited

+ 持有UNH

+13.24%

3個月報酬率

A

Allen Holding Inc.

+ 持有UNH

+13.12%

3個月報酬率

C

Compound Global Advisors, LLC

+ 持有UNH

+11.66%

3個月報酬率

事件時間軸

2026-10-14 (ET)

10:00:00

UnitedHealth and Others See Notable Gains

2026-10-13 (ET)

16:30:00

S&P 500 Earnings Expected to Grow 30% in Q3

12:30:00

S&P 500 Earnings Expected to Grow 30% in Q3

09:00:00

U.S. Stock Futures Mixed as Semiconductor Stocks Plunge

08:30:00

UnitedHealth Group Revises FY26 Guidance to 75% Star Plans

資訊

UNH 常見問題 —— 由 Alphio AI 解答

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

UnitedHealth Group is a good buy right now due to its solid fundamentals and positive market sentiment. The current price is $379.30, with a forward P/E ratio of 16.58, suggesting it is reasonably valued for future earnings growth. Additionally, analysts project earnings growth of over 13% annually in the next three to five years, which supports a bullish outlook. However, insider selling has surged by 2854.33% recently, indicating potential concerns about management confidence.

22 analysts cover UNH: 22 rate it Buy, 0 Hold and 0 Sell. The average price target is 397.82.

$UNH I look at this and remember, we're right back where we were one year ago 😂😂😂 @gpaisa @lextrading @JFDI @ArtOfTrends

展開
註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易